Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)

Clinical trial NCT05661188 · RECRUITING

Trial details

NCT number: NCT05661188
Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Anal Canal

Start date: 2023-02-14
Primary completion: 2027-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.